Clinical Trial Update: Tumor Antigen-sensitized DC Vaccine for Colorectal Cancer Liver Metastases [Phase 1]

View source ↗

Summary

An ongoing Phase 1 study evaluating a tumor antigen-sensitized dendritic cell vaccine for colorectal cancer with liver metastases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Tumor antigen-sensitized dendritic cell vaccine (dendritic cell vaccine)

Snippet

Sponsor: West China Hospital | Conditions: Carcinoma, Colorectal Cancer | Phase 1 | Status: RECRUITING